Bid Price | 10324.00p | High Price | 10386.00p |
---|
Ask Price | 10328.00p | Low Price | 10148.00p |
---|
Open Price | 10218.00p | Spread | 0.04% |
---|
Prev Close | 10218.00p | Volume | 1,762,578 |
---|
Astrazeneca PLC Historic Prices
Date | Open | High | Low | Close | Volume |
---|
Jul 7, 2025 | 10360.00 | 10367.95 | 10172.00 | 10218.00 | 821,187 |
Jul 4, 2025 | 10130.00 | 10416.00 | 10122.00 | 10336.00 | 927,347 |
Jul 3, 2025 | 10394.00 | 10466.00 | 10112.00 | 10204.00 | 1,996,860 |
Jul 2, 2025 | 10446.00 | 10468.00 | 10326.00 | 10390.00 | 1,305,789 |
More Astrazeneca PLC Historic Prices >Astrazeneca PLC Information
Name | Astrazeneca PLC | Index | FTSE 100 |
---|
ISIN | GB0009895292 | Epic | AZN |
---|
Type | Equity | Currency | GBX |
---|
Record Status | Active | Trading Segment | SET1 |
---|
Industry | Drug Manufacturers - General | Sector | Healthcare |
---|
EMS | 200 | Trading Status | Closed |
---|
Shares in Issue | 1.55 bn | Prev Close | 10218.00p |
---|
PE Ratio | 28.063511 | Market Cap | £160.29 bn |
---|
Div Yield | 2.4 | Div per Share | $2.12 |
---|
EPS | $1.87 | Div Cover | 0.8836 |
---|
PEG | 0.932 | EPS Growth (%) | 0.00 |
---|
ROCE | 0.043459 | DPS Growth (%) | 0.0409 |
---|
Current Ratio | 0.897353 | Quick Ratio | 0.640084 |
---|
Astrazeneca PLC Director Deals
Declared | Type | Director | Pos. | Volume / Price | Value |
---|
12/06/25 | TOUT | Aradhana Sarin | FD | 100 @ $0.00 | $0.00 |
23/05/25 | TIN | Pascal Soriot | CEO | 8,970 @ £0.00 | £0.00 |
01/05/25 | BUY | Karen Knudsen | NED | 700 @ $143.31 | $100,317.00 |
07/03/25 | TIN | Pascal Soriot | CEO | 89,962 @ £0.00 | £0.00 |
06/03/25 | DRIP | Pascal Soriot | CEO | 248 @ £0.00 | £0.00 |
06/03/25 | TIN | Pascal Soriot | CEO | 17,357 @ £0.00 | £0.00 |
06/03/25 | DRIP | Aradhana Sarin | FD | 28 @ £0.00 | £0.00 |
06/03/25 | TIN | Aradhana Sarin | FD | 2,021 @ £0.00 | £0.00 |
20/11/24 | BUY | Tony Mok | NED | 1,500 @ $126.80 | $190,195.00 |
15/11/24 | BUY | Pascal Soriot | CEO | 20,000 @ £102.03 | £2,040,600.00 |
More Astrazeneca PLC Director Deals >Astrazeneca PLC News